These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 14555277

  • 21. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T.
    J Exp Med; 2000 Jan 17; 191(2):275-86. PubMed ID: 10637272
    [Abstract] [Full Text] [Related]

  • 22. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.
    Woo JT, Nakagawa H, Notoya M, Yonezawa T, Udagawa N, Lee IS, Ohnishi M, Hagiwara H, Nagai K.
    Biol Pharm Bull; 2004 Apr 17; 27(4):504-9. PubMed ID: 15056855
    [Abstract] [Full Text] [Related]

  • 23. Immune interactions with CD4+ T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells.
    Alnaeeli M, Penninger JM, Teng YT.
    J Immunol; 2006 Sep 01; 177(5):3314-26. PubMed ID: 16920972
    [Abstract] [Full Text] [Related]

  • 24. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms.
    Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R.
    J Bone Miner Res; 2001 Feb 01; 16(2):328-37. PubMed ID: 11204433
    [Abstract] [Full Text] [Related]

  • 25. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.
    J Bone Miner Res; 2005 Sep 01; 20(9):1659-68. PubMed ID: 16059637
    [Abstract] [Full Text] [Related]

  • 26. Regulation of receptor activator of NF-kappa B ligand-induced osteoclastogenesis by endogenous interferon-beta (INF-beta ) and suppressors of cytokine signaling (SOCS). The possible counteracting role of SOCSs- in IFN-beta-inhibited osteoclast formation.
    Hayashi T, Kaneda T, Toyama Y, Kumegawa M, Hakeda Y.
    J Biol Chem; 2002 Aug 02; 277(31):27880-6. PubMed ID: 12023971
    [Abstract] [Full Text] [Related]

  • 27. The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells.
    Fujikawa Y, Sabokbar A, Neale SD, Itonaga I, Torisu T, Athanasou NA.
    Bone; 2001 Mar 02; 28(3):261-7. PubMed ID: 11248655
    [Abstract] [Full Text] [Related]

  • 28. LTB4 can directly stimulate human osteoclast formation from PBMC independent of RANKL.
    Jiang J, Lv HS, Lin JH, Jiang DF, Chen ZK.
    Artif Cells Blood Substit Immobil Biotechnol; 2005 Mar 02; 33(4):391-403. PubMed ID: 16317958
    [Abstract] [Full Text] [Related]

  • 29. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
    Mirosavljevic D, Quinn JM, Elliott J, Horwood NJ, Martin TJ, Gillespie MT.
    J Bone Miner Res; 2003 Jun 02; 18(6):984-93. PubMed ID: 12817750
    [Abstract] [Full Text] [Related]

  • 30. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N.
    Endocrinology; 2001 Aug 02; 142(8):3656-62. PubMed ID: 11459815
    [Abstract] [Full Text] [Related]

  • 31. Presence of osteoclast precursors in colonies cloned in the presence of hematopoietic colony-stimulating factors.
    Yamazaki H, Kunisada T, Yamane T, Hayashi SI.
    Exp Hematol; 2001 Jan 02; 29(1):68-76. PubMed ID: 11164107
    [Abstract] [Full Text] [Related]

  • 32. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
    Uchiyama S, Yamaguchi M.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1297-305. PubMed ID: 15013845
    [Abstract] [Full Text] [Related]

  • 33. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
    Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH.
    Bone; 2002 Jan 01; 30(1):71-7. PubMed ID: 11792567
    [Abstract] [Full Text] [Related]

  • 34. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
    Hirayama T, Danks L, Sabokbar A, Athanasou NA.
    Rheumatology (Oxford); 2002 Nov 01; 41(11):1232-9. PubMed ID: 12421995
    [Abstract] [Full Text] [Related]

  • 35. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
    Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T.
    Biochem Biophys Res Commun; 1998 May 08; 246(1):199-204. PubMed ID: 9600092
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.
    Biochem Biophys Res Commun; 2005 Apr 15; 329(3):839-45. PubMed ID: 15752732
    [Abstract] [Full Text] [Related]

  • 37. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C, Riggs BL, Khosla S.
    Calcif Tissue Int; 2002 Nov 15; 71(5):437-46. PubMed ID: 12202955
    [Abstract] [Full Text] [Related]

  • 38. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
    Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, Lou H, Delaissé JM, Foged NT.
    J Biol Chem; 2003 Nov 07; 278(45):44975-87. PubMed ID: 12933809
    [Abstract] [Full Text] [Related]

  • 39. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep 07; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 40. Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis.
    Grcević D, Lee SK, Marusić A, Lorenzo JA.
    J Immunol; 2000 Oct 15; 165(8):4231-8. PubMed ID: 11035056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.